Inventor · disambiguated record
Matthias Austen
Also filed as: AUSTEN MATTHIAS
8 granted patents·13 pending applications·33 citations·filing 2004–2023
82Inventor score
Top patents by PatentIndex Score
21 records- 0186US8399408B2Method for treating diabetes using neurturinAUSTEN MATTHIAS·Filed 2011·Granted Mar 19, 2013·16 cites·7 claims
- 0281US8853193B2Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositionsHECKEL ARMIN·Filed 2011·Granted Oct 7, 2014·7 cites·11 claims
- 0378US8754079B2Cycloalkyl containing thienopyrimidines for pharmaceutical compositionsLEHMANN-LINTZ THORSTEN·Filed 2011·Granted Jun 17, 2014·6 cites·13 claims
- 0475US8486953B2Thienopyrimidines for pharmaceutical compositionsAUSTEN MATTHIAS·Filed 2009·Granted Jul 16, 2013·3 cites·17 claims
- 0564US8772233B2Method for promoting regeneration of pancreatic beta-cells by administering neurturinDEVELOGEN AG·Filed 2013·Granted Jul 8, 2014·1 cites·18 claims
- 0664US2025283046A1New Cell Populations and Means and Methods for their Differentiation and PreservationEVOTEC INT GMBH·Filed 2023·Application pending·0 cites
- 0755US2014274897A1Method for preventing and treating diabetes using neurturinEVOTEC INTERNAT GMBH·Filed 2014·Application pending·0 cites
- 0853US2008241106A1Method for Preventing and Treating Diabetes Using NeurturinAUSTEN MATTHIAS·Filed 2004·Application pending·0 cites
- 0947US2010247517A1Use of mnk inhibitors for the treatment of alzheimer's diseaseBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 1045US2009258829A1New formulation for increasing bioavailability of neurturinHARDER FRIEDRICH·Filed 2007·Application pending·0 cites
- 1142US9029323B2Neurturin conjugates for pharmaceutical useAUSTEN MATTHIAS·Filed 2010·Granted May 12, 2015·0 cites·39 claims
- 1242US2014162948A1Formulation for increasing bioavailability of neurturinEVOTEC INTERNAT GMBH·Filed 2013·Application pending·0 cites
- 1342US2013231283A1Novel neurturin conjugates for pharmaceutical useDEVELOGEN AG·Filed 2013·Application pending·0 cites
- 1440US2013053313A1New formulation for increasing bioavailability of neurturinHARDER FRIEDRICH·Filed 2012·Application pending·0 cites
- 1540US2008207594A1Use of Gsk-3 Inhibitors for Preventing and Treating Pancreatic Autoimmune DisordersDAVELOGEN AG·Filed 2006·Application pending·0 cites
- 1639US2007110728A1Method for preventing and treating diabetes using dg119DEVELOGEN AG·Filed 2004·Application pending·0 cites
- 1738US2005222070A1Pancreas-specific proteinsDEVELOGEN AG·Filed 2004·Application pending·0 cites
- 1837US9049849B2Screening methods for compounds useful for treating pancreatic dysfunctionDOHRMANN CORD·Filed 2011·Granted Jun 9, 2015·0 cites·17 claims
- 1936US2013065914A1Halogen or cyano substituted thieno [2,3-d]pyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositionsHECKEL ARMIN·Filed 2011·Application pending·0 cites
- 2036US2016060317A1Novel neurturin conjugates for pharmaceutical useEVOTEC INTERNAT GMBH·Filed 2015·Application pending·0 cites
- 2134US8648068B2Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositionsLEHMANN-LINTZ THORSTEN·Filed 2011·Granted Feb 11, 2014·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Matthias Austen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →